Systemic lupus erythematosus disease Market is Expected to Grow at an Impressive

Posted by shriya on June 9th, 2021

Global Systemic Lupus Erythematosus Treatment Market Research Report: By Treatment (Corticosteroids, Nonsteroidal anti-inflammatory drugs, Antimalarials, Immunosuppressive agents and immune modulators), By Route of Administration (Oral, Intravenous, Subcutaneous) and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Forecast to 2027

Market Highlights

According to MRFR analysis, systemic lupus erythematosus disease Market is expected to register a CAGR of 6% during the forecast period of 2019 to 2025 and was valued at USD 1.06 Billion in 2018. Systemic lupus erythematosus (SLE) is an autoimmune disease in which the body attacks its healthy cells. The organs affected in the disease can be joints, skin, brain, and kidney amongst others. Causes of SLE can be genetic, hormonal, environmental or side effects of other medicines.

Regional Analysis

The market has been divided, by region, into Europe, the Americas, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the presence of key players and high healthcare expenditure. Europe holds the second-largest market share. The European systemic lupus erythematosus treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The growth of global systemic lupus erythematosus treatment market is driven by various factors such as High prevalence & incidence of systemic lupus erythematosus, product launches by key players, strong product pipeline, and increasing awareness regarding systemic lupus erythematosus. However, the stringent regulatory policies and side effects of medications are expected to curb the growth of the global systemic lupus erythematosus treatment market.

Key Players

Some of the key players in the Global Systemic Lupus Erythematosus Treatment Market are Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), AstraZeneca (UK), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), Amgen Inc. (US), Anthera (US), and Johnson & Johnson Services, Inc. (US).

Browse More Details at:


Akash Anand

Market Research Future

+1 646 845 9312


Like it? Share it!


About the Author

Joined: May 18th, 2021
Articles Posted: 81

More by this author